| Dr Steve A Joselow, MD | |
|
23 Hampton Rd, Exeter, NH 03833-4807 | |
| (603) 772-4684 | |
| (603) 772-5206 |
| Full Name | Dr Steve A Joselow |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Location | 23 Hampton Rd, Exeter, New Hampshire |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801991351 | NPI | - | NPPES |
| P00266192 | Other | ME | RAILROAD MEDICARE |
| P00352752 | Other | NH | RAILROAD MEDICARE |
| 070002678 | Other | MA | RAILROAD MEDICARE |
| A58205 | Other | MA | HARVARD |
| 012217 | Other | ME | ANTHEM MAINE |
| 0105727Y0NH01 | Other | NH | ANTHEM NEW HAMPSHIRE |
| 4037118 | Other | MA | AETNA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 7053 (New Hampshire) | Primary |
| 207N00000X | Dermatology | 012501 (Maine) | Secondary |
| Entity Name | Northeast Dermatology Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104921162 PECOS PAC ID: 3072403799 Enrollment ID: O20040317000864 |
News Archive
A radically different approach to treating high blood pressure – using a minimally invasive procedure – is being evaluated as part of a Pivotal Phase III 90-site national trial that includes The Carl H. and Edyth Lindner Center for Research and Education at The Christ Hospital.
By launching Sona, the Sonova Group is introducing a novel business concept combining a specialized product portfolio with easy fitting and simplified logistic processes, which are unique in the industry. The new brand broadens the portfolio of the established hearing solutions of Phonak and Unitron and is aimed at the market segment for mild-to-moderate hearing loss. It features mainly the integrated service concept providing audiologists with new opportunities to make their hearing solutions more accessible to consumers.
Higher levels of phosphorus in the blood are linked to increased calcification of the coronary arteries— a key marker of heart disease risk, according to a study in an upcoming issue of Clinical Journal of the American Society of Nephrology (CJASN). "This may help to explain why even early-stage chronic kidney disease (CKD) is associated with increased cardiovascular risk that is not otherwise explained by traditional risk factors," comments Katherine R. Tuttle, MD (Providence Medical Research Center, Spokane, WA).
Isis Pharmaceuticals, Inc. announced today positive results from a Phase 1 study with ISIS-FXIRx. The results demonstrated that treatment with ISIS-FXIRx produced dose-dependent statistically significant reductions of up to 78 percent in Factor XI activity.
A group of health care leaders, including a University of Massachusetts Amherst nurse innovator, has published a national call to action to prevent non-ventilator-associated, hospital-acquired pneumonia (NVHAP).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Steve A Joselow, MD 401 Andover St, Suite 101, North Andover, MA 01845-5076 Ph: (978) 691-5690 | Dr Steve A Joselow, MD 23 Hampton Rd, Exeter, NH 03833-4807 Ph: (603) 772-4684 |
News Archive
A radically different approach to treating high blood pressure – using a minimally invasive procedure – is being evaluated as part of a Pivotal Phase III 90-site national trial that includes The Carl H. and Edyth Lindner Center for Research and Education at The Christ Hospital.
By launching Sona, the Sonova Group is introducing a novel business concept combining a specialized product portfolio with easy fitting and simplified logistic processes, which are unique in the industry. The new brand broadens the portfolio of the established hearing solutions of Phonak and Unitron and is aimed at the market segment for mild-to-moderate hearing loss. It features mainly the integrated service concept providing audiologists with new opportunities to make their hearing solutions more accessible to consumers.
Higher levels of phosphorus in the blood are linked to increased calcification of the coronary arteries— a key marker of heart disease risk, according to a study in an upcoming issue of Clinical Journal of the American Society of Nephrology (CJASN). "This may help to explain why even early-stage chronic kidney disease (CKD) is associated with increased cardiovascular risk that is not otherwise explained by traditional risk factors," comments Katherine R. Tuttle, MD (Providence Medical Research Center, Spokane, WA).
Isis Pharmaceuticals, Inc. announced today positive results from a Phase 1 study with ISIS-FXIRx. The results demonstrated that treatment with ISIS-FXIRx produced dose-dependent statistically significant reductions of up to 78 percent in Factor XI activity.
A group of health care leaders, including a University of Massachusetts Amherst nurse innovator, has published a national call to action to prevent non-ventilator-associated, hospital-acquired pneumonia (NVHAP).
› Verified 8 days ago
Dr. Sarah Anne Pace, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 23 Hampton Rd, Exeter, NH 03833 Phone: 978-691-5690 Fax: 978-691-5693 | |
Heidi Elizabeth Kipers Mullen, D.O. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 23 Hampton Rd, Exeter, NH 03833 Phone: 978-691-5690 |